Wayground logo

Free Printable Worksheets

Font size

S
M
L
XL
Worksheets

Clostridioides difficile Infections Quiz

Total questions: 15

Worksheet time: 8mins

Name
Class
Date
1.

What is the etiological agent of Clostridioides difficile infections (CDI)?

a)

Gram-negative, non-spore-forming bacillus

b)

Gram-positive, spore-forming bacillus

c)

Gram-negative, spore-forming bacillus

d)

Gram-positive, non-spore-forming bacillus

2.

What percentage of CDI cases are nosocomial?

a)

10-20%

b)

25-50%

c)

66-75%

d)

80-90%

3.

Which of the following is a sign of CDI?

a)

Constipation

b)

Profuse, watery or mucoid green, foul diarrhea

c)

Mild abdominal pain

d)

Low fever

4.

What is the role of antibiotics in CDI pathogenesis?

a)

They prevent toxin production

b)

They stimulate toxin production

c)

They have no effect on toxin production

d)

They eliminate toxin production

5.

What is the typical leukocyte count in fulminant CDI?

a)

<5,000/mm³

b)

5,000-10,000/mm³

c)

>15,000/mm³

d)

10,000-15,000/mm³

6.

What is the most sensitive method for diagnosing CDI?

a)

Stool culture

b)

Nucleic acid amplification test (NAAT)

c)

Enzyme immunoassay

d)

BD-GeneOhm™ C. difficile real-time PCR assay

7.

What is the preferred treatment for an initial CDI episode according to the 2021 IDSA guidelines?

a)

Vancomycin 125 mg PO QID for 10 days

b)

Metronidazole 500 mg PO TID for 10-14 days

c)

Fidaxomicin 200 mg PO BID for 10 days

d)

Rifaximin 400 mg TID for 20 days

8.

What is the recommended treatment for a first CDI recurrence?

a)

Fidaxomicin 200 mg PO BID for 10 days

b)

Vancomycin 125 mg PO QID for 10 days

c)

Metronidazole 500 mg PO TID for 10-14 days

d)

Rifaximin 400 mg TID for 20 days

9.

What is a common side effect of metronidazole?

a)

Bitter taste

b)

Dysgeusia (bad taste)

c)

High cost

d)

Low efficacy

10.

What is the availability of Bezlotoxumab in terms of dosage?

a)

1000 mg/40 ml single use vial

b)

500 mg/20 ml single use vial

c)

2000 mg/80 ml single use vial

d)

750 mg/30 ml single use vial

11.

What is the effect of oral vancomycin on recurrent CDI according to the study?

a)

No effect

b)

Significantly lower incidence

c)

Increased incidence

d)

Unchanged incidence

12.

What was the incidence of recurrent CDI in patients receiving placebo?

a)

4.2%

b)

10.5%

c)

26.6%

d)

15.8%

13.

What is a limitation of the study on oral vancomycin for recurrent CDI?

a)

Small sample size

b)

Lack of determination of effect on intestinal flora

c)

Short duration

d)

High cost

14.

What is the primary focus of environmental cleaning in CDI prevention?

a)

Increase humidity

b)

Identify and remove environmental sources

c)

Add more plants

d)

Use air fresheners

15.

What type of study was conducted on oral vancomycin for recurrent CDI?

a)

Prospective study

b)

Retrospective study

c)

Randomized controlled trial

d)

Case study